Literature DB >> 24664371

Karyopherin a2 and chromosome region maintenance protein 1 expression in meningiomas: novel biomarkers for recurrence and malignant progression.

Konstantinos Gousias1, Pitt Niehusmann2, Gerrit H Gielen2, Matthias Simon3.   

Abstract

The karyopherin protein family comprises importins and exportins which are nucleocytoplasmic shuttling receptors. Increased levels of karyopherin a2 and chromosome region maintenance protein 1 correlate with a higher WHO grade and a poorer prognosis in patients with infiltrative astrocytomas. The aim of this study was to evaluate representative members of importins and exportins (i.e. karyopherin a2 and chromosome region maintenance protein 1) as novel biomarkers for meningiomas of WHO grades I-III. We semiquantitatively analyzed nuclear expression of karyopherin a2, chromosome region maintenance protein 1 and the MIB1 labeling index using immunohistochemistry in 108 primary (44 meningiomas WHO grade I, 48 meningiomas WHO grade II, 16 meningiomas WHO grade III) and 13 recurrent meningiomas. Statistical analysis was performed using standard techniques. Karyopherin a2 (p < 0.001) and chromosome region maintenance protein 1 (p = 0.002) expression correlated significantly with the histological grade. Karyopherin a2 expression correlated with proliferative activity as assessed by the MIB1 index (p < 0.001). Recurrent tumors expressed significantly higher levels of karyopherin a2 (p = 0.045) when compared to primary growths. Multivariate analysis of the overall series as well as of patients with atypical meningiomas identified higher karyopherin a2 (≥ 5 vs. <5%) and chromosome region maintenance protein 1 (≥ 60 vs. 60%) expression as independent predictors of tumor recurrence. Karyopherin a2 and chromosome region maintenance protein 1 expression may have potential as novel biomarkers for meningiomas.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24664371     DOI: 10.1007/s11060-014-1423-4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  32 in total

1.  Truncated form of importin alpha identified in breast cancer cell inhibits nuclear import of p53.

Authors:  I S Kim; D H Kim; S M Han; M U Chin; H J Nam; H P Cho; S Y Choi; B J Song; E R Kim; Y S Bae; Y H Moon
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

Review 2.  Nuclear export of proteins and drug resistance in cancer.

Authors:  Joel G Turner; Jana Dawson; Daniel M Sullivan
Journal:  Biochem Pharmacol       Date:  2011-12-20       Impact factor: 5.858

3.  Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas.

Authors:  Soichi Oya; Kensuke Kawai; Hirofumi Nakatomi; Nobuhito Saito
Journal:  J Neurosurg       Date:  2012-05-04       Impact factor: 5.115

4.  Nuclear transport receptor karyopherin-α2 promotes malignant breast cancer phenotypes in vitro.

Authors:  E Noetzel; M Rose; J Bornemann; M Gajewski; R Knüchel; E Dahl
Journal:  Oncogene       Date:  2011-09-12       Impact factor: 9.867

5.  Overexpression of NBS1 contributes to transformation through the activation of phosphatidylinositol 3-kinase/Akt.

Authors:  Yen-Chung Chen; Yi-Ning Su; Po-Chien Chou; Wei-Chung Chiang; Ming-Cheng Chang; Liang-Shun Wang; Shu-Chun Teng; Kou-Juey Wu
Journal:  J Biol Chem       Date:  2005-07-21       Impact factor: 5.157

6.  CRM1 blockade by selective inhibitors of nuclear export attenuates kidney cancer growth.

Authors:  Hiromi Inoue; Michael Kauffman; Sharon Shacham; Yosef Landesman; Joy Yang; Christopher P Evans; Robert H Weiss
Journal:  J Urol       Date:  2012-10-16       Impact factor: 7.450

7.  Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis.

Authors:  Aiguo Shen; Yuchan Wang; Yueming Zhao; Lin Zou; Linlin Sun; Chun Cheng
Journal:  Neurosurgery       Date:  2009-07       Impact factor: 4.654

8.  The expression of CRM1 is associated with prognosis in human osteosarcoma.

Authors:  Yang Yao; Yang Dong; Feng Lin; Hui Zhao; Zan Shen; Ping Chen; Yuan-Jue Sun; Li-Na Tang; Shui-Er Zheng
Journal:  Oncol Rep       Date:  2009-01       Impact factor: 3.906

Review 9.  Intracranial meningiomas of atypical (WHO grade II) histology.

Authors:  Leland Rogers; Mark Gilbert; Michael A Vogelbaum
Journal:  J Neurooncol       Date:  2010-08-26       Impact factor: 4.130

10.  The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation.

Authors:  Pauline J van der Watt; Christopher P Maske; Denver T Hendricks; M Iqbal Parker; Lynette Denny; Dhirendra Govender; Michael J Birrer; Virna D Leaner
Journal:  Int J Cancer       Date:  2009-04-15       Impact factor: 7.396

View more
  5 in total

1.  Low cytoplasmic and nuclear KPNA2 expression in radiotherapy-treated head and neck squamous cell cancer is associated with an adverse outcome.

Authors:  Pia B Erben; Kathrin Brunner; Markus Hecht; Marlen Haderlein; Maike Büttner-Herold; Abbas Agaimy; Rainer Fietkau; Arndt Hartmann; Luitpold V Distel
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

Review 2.  Prognostic value of increased KPNA2 expression in some solid tumors: A systematic review and meta-analysis.

Authors:  Li-Na Zhou; Yue Tan; Ping Li; Ping Zeng; Min-Bin Chen; Ye Tian; Ya-Qun Zhu
Journal:  Oncotarget       Date:  2017-01-03

3.  Silencing of the nucleocytoplasmic shuttling protein karyopherin a2 promotes cell-cycle arrest and apoptosis in glioblastoma multiforme.

Authors:  Ramon Martinez-Olivera; Angeliki Datsi; Maren Stallkamp; Manfred Köller; Isabelle Kohtz; Bogdan Pintea; Konstantinos Gousias
Journal:  Oncotarget       Date:  2018-09-11

Review 4.  Receptor Tyrosine Kinases as Candidate Prognostic Biomarkers and Therapeutic Targets in Meningioma.

Authors:  Rafael Roesler; Barbara Kunzler Souza; Gustavo R Isolan
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

Review 5.  Mechanisms of Cell Cycle Arrest and Apoptosis in Glioblastoma.

Authors:  Konstantinos Gousias; Theocharis Theocharous; Matthias Simon
Journal:  Biomedicines       Date:  2022-02-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.